Johnson & Johnson (JNJ)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $680.19B
Last updated: Nov 17, 2026 at 4:43 PM ET
Johnson & Johnson (JNJ) Stock Chart
Johnson & Johnson (JNJ) has a latest price of $278.82 on Nov 17, 2026, 3.9% below its 52-week high of $290.25. Its price rose 44.0% over the past 12 months. The month-end price rose 135.5% over the 10 years through Oct 2026, a compound annual rate of 8.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $273.20 in Oct 2026 and its lowest $111.30 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart JNJ with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for JNJ.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 2.5%, and over 6 months it rose 22.5%. The month-end price rose 84.2% over the 3 years through Oct 2026, a compound annual rate of 22.6%.
| Period | Change |
|---|---|
| 1 month | +9.9% |
| 3 months | +2.5% |
| 6 months | +22.5% |
| 12 months | +44.0% |
| 12 months, with dividends | +46.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +84.2% | +22.6% |
| 5 years | +67.7% | +10.9% |
| 10 years | +135.5% | +8.9% |
Price by Year
Its best calendar year was 2025, when the price rose 43.1%, and its weakest was 2023, when it fell 11.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $273.20 | +32.0% |
| 2025 | $206.95 | +43.1% |
| 2024 | $144.62 | -7.7% |
| 2023 | $156.74 | -11.3% |
| 2022 | $176.65 | +3.3% |
| 2021 | $171.07 | +8.7% |
| 2020 | $157.38 | +7.9% |
| 2019 | $145.87 | +13.0% |
| 2018 | $129.05 | -7.6% |
| 2017 | $139.72 | +21.3% |
Trading Range
The price is 4.3% above its 50-day average of $267.20 and 11.9% above its 200-day average of $249.11.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $278.82 | |
| 52-week high | $290.25 | -3.9% |
| 52-week low | $194.99 | +43.0% |
| 50-day average | $267.20 | +4.3% |
| 200-day average | $249.11 | +11.9% |
Price Risk
Over 3 years, its largest fall from a peak was 14.5%.
| Measure | Value |
|---|---|
| 1-year beta | -0.05 |
| Largest fall, 1 year | -11.4% |
| Largest fall, 3 years | -14.5% |
Valuation
Johnson & Johnson traded at 19.2x earnings at the end of 2025, against a 5-year median of 16.4x and a 10-year median of 17.1x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About JNJ
What is JNJ's 1-year price change?
Johnson & Johnson's price rose 44.0% over the past 12 months. With dividends included, the 12-month total return was 46.7%.
What is JNJ's 5-year price change?
Johnson & Johnson's month-end price rose 67.7% over the 5 years through Oct 2026, a compound annual rate of 10.9%. These figures leave out dividends.
What is JNJ's 52-week high and low?
Johnson & Johnson's 52-week high is $290.25 and its 52-week low is $194.99. Its latest price of $278.82 on Nov 17, 2026 is 3.9% below the high.
What is JNJ's beta?
Johnson & Johnson's 1-year beta against the S&P 500 is -0.05, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 11.4%.
Is the JNJ chart free?
Yes. Advanced Charting for JNJ is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
JNJ pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts